FI830813L - Foerfarande foer omvandling av pre-proinsulinanaloger till insulin - Google Patents

Foerfarande foer omvandling av pre-proinsulinanaloger till insulin

Info

Publication number
FI830813L
FI830813L FI830813A FI830813A FI830813L FI 830813 L FI830813 L FI 830813L FI 830813 A FI830813 A FI 830813A FI 830813 A FI830813 A FI 830813A FI 830813 L FI830813 L FI 830813L
Authority
FI
Finland
Prior art keywords
proinsulinanaloger
overclosing
till
insulin
foer faring
Prior art date
Application number
FI830813A
Other languages
English (en)
Other versions
FI79117B (fi
FI79117C (fi
FI830813A0 (fi
Inventor
Rainer Obermeier
Rolf Geiger
Ulrich Grau
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI830813A0 publication Critical patent/FI830813A0/fi
Publication of FI830813L publication Critical patent/FI830813L/fi
Publication of FI79117B publication Critical patent/FI79117B/fi
Application granted granted Critical
Publication of FI79117C publication Critical patent/FI79117C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/26Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI830813A 1982-03-13 1983-03-10 Foerfarande foer framstaellning av bovine-, svin- eller humaninsulin. FI79117C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3209184 1982-03-13
DE19823209184 DE3209184A1 (de) 1982-03-13 1982-03-13 Verfahren zur umwandlung von praeproinsulinanaloga zu insulinen

Publications (4)

Publication Number Publication Date
FI830813A0 FI830813A0 (fi) 1983-03-10
FI830813L true FI830813L (fi) 1983-09-14
FI79117B FI79117B (fi) 1989-07-31
FI79117C FI79117C (fi) 1989-11-10

Family

ID=6158163

Family Applications (1)

Application Number Title Priority Date Filing Date
FI830813A FI79117C (fi) 1982-03-13 1983-03-10 Foerfarande foer framstaellning av bovine-, svin- eller humaninsulin.

Country Status (15)

Country Link
US (1) US4639333A (fi)
EP (1) EP0089007B1 (fi)
JP (1) JPS58190398A (fi)
KR (1) KR900003502B1 (fi)
AT (1) ATE21118T1 (fi)
AU (1) AU553832B2 (fi)
CA (1) CA1195273A (fi)
DE (2) DE3209184A1 (fi)
DK (1) DK154573C (fi)
ES (1) ES520493A0 (fi)
FI (1) FI79117C (fi)
GR (1) GR78453B (fi)
IE (1) IE54605B1 (fi)
IL (1) IL68103A (fi)
ZA (1) ZA831693B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326472A1 (de) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
DE3333640A1 (de) * 1983-09-17 1985-04-25 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung
US4569791A (en) * 1984-06-14 1986-02-11 Eli Lilly And Company Anti-diabetic compounds
US4581165A (en) * 1984-06-14 1986-04-08 Eli Lilly And Company Anti-diabetic compounds
US4569792A (en) * 1984-06-14 1986-02-11 Eli Lilly And Company Anti-diabetic compounds
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
EP0280534B1 (en) * 1987-02-25 1993-04-21 Novo Nordisk A/S Novel insulin derivatives
US5514646A (en) * 1989-02-09 1996-05-07 Chance; Ronald E. Insulin analogs modified at position 29 of the B chain
IL99383A (en) * 1990-09-05 1996-01-31 Hoechst Ag An enzymatic process for the conversion of pre-insulin into insulin
PL2307441T3 (pl) 2008-08-07 2016-09-30 Sposób otrzymywania związków insuliny

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3276961A (en) * 1963-04-08 1966-10-04 Squibb & Sons Inc Process for preparing human insulin
GB1426061A (en) * 1972-12-28 1976-02-25 Ici Ltd Polypeptides
US3903068A (en) * 1972-12-26 1975-09-02 Us Health Education & Welfare Facile synthesis of human insulin by modification of porcine insulin
JPS55138393A (en) * 1979-04-13 1980-10-29 Shionogi & Co Ltd Semisynthesis of insulin
EP0017938B1 (en) * 1979-04-13 1983-08-03 Shionogi & Co., Ltd. Process for preparing a b30-threonine insulin
DK147437A (en) * 1980-02-11 1900-01-01 Process for preparing human insulin or threonine B30 esters of human insulin, or a salt or complex thereof
PH16156A (en) * 1980-03-27 1983-07-18 Lilly Co Eli Process for producing an insulin precursor
DK319780A (da) * 1980-07-24 1982-01-25 Forenede Bryggerier As Fremgangsmaade til enzymatisk udskiftning af b-30 aminosyren i insuliner
DE3101382A1 (de) * 1981-01-17 1982-09-02 Hoechst Ag, 6000 Frankfurt "verfahren zur herstellung von humanisulin oder dessen derivaten aus schweineinsulin oder dessen derivaten"

Also Published As

Publication number Publication date
DE3209184A1 (de) 1983-09-15
DK154573B (da) 1988-11-28
KR900003502B1 (ko) 1990-05-21
DK117883D0 (da) 1983-03-11
ES8401448A1 (es) 1983-12-16
AU1242883A (en) 1983-09-15
ZA831693B (en) 1983-11-30
DK117883A (da) 1983-09-14
US4639333A (en) 1987-01-27
JPH0536034B2 (fi) 1993-05-28
CA1195273A (en) 1985-10-15
IE830529L (en) 1983-09-13
DK154573C (da) 1989-05-22
IL68103A (en) 1986-01-31
EP0089007B1 (de) 1986-07-30
FI79117B (fi) 1989-07-31
ES520493A0 (es) 1983-12-16
AU553832B2 (en) 1986-07-31
KR840004169A (ko) 1984-10-10
JPS58190398A (ja) 1983-11-07
FI79117C (fi) 1989-11-10
IE54605B1 (en) 1989-12-06
GR78453B (fi) 1984-09-27
DE3364838D1 (en) 1986-09-04
FI830813A0 (fi) 1983-03-10
ATE21118T1 (de) 1986-08-15
EP0089007A1 (de) 1983-09-21
IL68103A0 (en) 1983-06-15

Similar Documents

Publication Publication Date Title
GR80366B (en) Method for the preparation of insulin derivatives with a lengthened b-chain c-terminal, novel basic modified insulin derivatives, medicaments containing them and use thereof
FI880017A (fi) Menetelmä haiman erittämän trypsiini-inhibiittorivarianttien valmistamiseksi ja menetelmässä käytettävä DNA, vektori ja isäntäsolu
FI830813L (fi) Foerfarande foer omvandling av pre-proinsulinanaloger till insulin
DE3264149D1 (en) Process for the preparation of human insulin or its derivatives from pig insulin or its derivatives
FI843045A0 (fi) Foerfarande foer framstaellning av insulinderivat.
GB8906156D0 (en) Production and use of anthelmintic agents and protective immunogens

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT